Warning: Invalid argument supplied for foreach() in /html/typo3/typo3conf/ext/akenzo_lr_country/Classes/Utility/Redirect.php on line 408
Workshop for the specialist press - The Challenge of DFS - Lohmann & Rauscher

Súhlasím s tým, aby táto stránka na analýzy, personalizované obsahy a reklamu používala súbory cookie.

The Challenge of Diabetic Foot

Networked, committed, professional.

There are currently about eight million people with diabetes in Germany – and the number is growing. One late complication of this metabolic disease is foot ulcers, which often ultimately require amputation. In view of this situation involving ever higher stakes for both the patient and those providing treatment, L&R organized a press workshop in Vienna on 27 January 2016 entitled “Innovative Wound Therapy – the Challenge of Diabetic Foot” Together with users and medical journalists, Wolfgang Süßle, CEO and President, and Dr Christian Rohrer, Head of Research and Development, outlined structural solutions focused on the needs of users and patients. The consensus of the experts was that innovative, interdisciplinary wound management can help improve outcomes considerably. To meet the challenge of DF, the essential conditions for wound healing, i.e. an interdisciplinary network and effective local wound therapy, must be optimized.

Avoidable surgeries

As Dr Claudia Ellert, consultant in vascular surgery, Lahn-Dill-Kliniken, Wetzlar, explained, among the challenges of this metabolic disease are late complications such as diabetic foot, which affects approximately one in four people with diabetes in their lifetime. She added, “Diabetic foot is the most common cause of amputation in Germany. In many cases, amputation could have been avoided with a multidisciplinary treatment approach.”

As Anita Mysor, wound manager, Krefeld/Berlin, explained, “The development of diabetic foot ulcers in the long term can be best avoided by effective wound management which fully addresses the question as to why a wound develops where it does. Both pressure protection and patient counseling and training are important factors here.” Lower leg ulcers covering a large surface area in particular tend to have a protracted course in inpatient and outpatient settings. Following debridement, dressings appropriate for the wound healing phase are applied to the wound. “The aim is to promote granulation and epithelization of the wound,” explained Anita Mysor.

Using negative pressure therapy

As Dr Claudia Ellert pointed out, negative pressure therapy is considered the gold standard in the treatment of complex wounds following debridement. Data from Armstrong et al.1 also confirm the benefits of negative pressure therapy: In 162 patients who underwent minor amputation due to diabetic foot, the healing rate after 112 days with negative pressure therapy was 56% compared to 39% with conventional moist wound management. The time to wound healing was 56 and 77 days, respectively. Dr Claudia Ellert summarized the findings as follows: “These results show that negative pressure therapy leads to more effective wound healing and wound closure, provides a better quality of life for the patient and results in shorter hospital stays and thus lower treatment costs.” Whereas the application of negative pressure dressings often used to be difficult and very time-consuming, it is now easy, fast and gentle on the skin with the innovative Suprasorb CNP EasyDress. The negative pressure dressing is applied considerably more quickly than is the case with conventional dressing methods. This translates to time savings of up to 90%.2

Vernetzt und innovativ

Nicht nur ist ein enger Austausch mit Anwendern aus stationären und ambulanten Versorgungsstrukturen von entscheidender Bedeutung. Dr. Christian Rohrer, Leiter der Division Forschung und Entwicklung, verdeutlichte zudem: „Damit uns Innovationen gelingen, institutionalisierten wir den Prozess eines Innovationsmanagements, spüren Technologien und Ideen auf, evaluieren sie und setzen sie in kooperativer, vertraulicher Zusammenarbeit mit Anwendern und Patienten um.“ Zuallererst sind die Bedürfnisse der Ärzte, Pflegenden und Wundexperten zu verstehen, und sie dann mit optimalen Versorgungslösungen zu befriedigen. „Das dehnt unsere Aufgabe über das Angebot einer optimalen Produktlösung hinweg aus“, beschrieb Wolfgang Süßle, Vorsitzender der Geschäftsführung: „Denn um Problemstellungen zu lösen, gilt es, über das alleinige Produkt hinausgehenden Service, Konzepte bzw. Orientierung zu geben, sowie mittels praxisorientierter, wissenschaftlich fundierter Guidelines und Empfehlungen die Versorgung zu unterstützen.“ Und der Erfolg gibt dem Unternehmen recht: L&R konnte im vergangenen Jahr seine internationale Präsenz in den unterschiedlichsten Regionen stark ausbauen, vor allem in den USA, China, Nord-Afrika und im Mittleren Osten. Der Konzern erzielte 2015 einen Jahresumsatz von mehr als 557 Millionen Euro – eine Steigerung zum Vorjahr von 6,4 Prozent. 

 

Sources:

(1) Armstrong et al. Negative Pressure Wound Therapy After Partial Diabetic Foot Amputation Negative. Lancet, 2005

(2) Duft M, Ostapowicz D, de Lange S, Griesshammer K, Abel M: Audit on the usability, user and patient satisfaction of tubular bandage. Multi-center international post-marketing study under real conditions, 2015